Enter the first few characters of Company and click 'Go'
Half Yearly Results of Marksans Pharma Ltd.(Figures in Rs crores)
|
|
Sep 30, 2023 |
Mar 31, 2023 |
Sep 30, 2022 |
Mar 31, 2022 |
Sep 30, 2021 |
Net Sales / Income |
386.71 |
325.79 |
329.41 |
342.21 |
316.07 |
Other Income |
48.55 |
20.02 |
40.47 |
19.71 |
22.54 |
Net Profit/Loss |
75.48 |
43.43 |
59.44 |
47.48 |
56.50 |
Raw Material |
185.62 |
168.24 |
170.25 |
163.64 |
164.35 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
35.16 |
29.21 |
26.87 |
30.50 |
29.96 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
105.53 |
88.09 |
90.81 |
89.98 |
62.24 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
0.49 |
1.51 |
2.11 |
1.96 |
1.83 |
Gross Profit |
112.12 |
65.04 |
83.74 |
72.44 |
79.73 |
Depreciation |
13.22 |
7.69 |
9.05 |
9.13 |
8.53 |
Taxation |
23.42 |
13.92 |
15.25 |
15.82 |
14.70 |
Extra Ordinary Item |
0 |
0 |
0 |
0 |
0 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
45.32 |
45.32 |
40.42 |
40.93 |
40.93 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
1.67 |
0.96 |
1.47 |
1.16 |
1.38 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article